School of Medicine

Julian Fleischman, an associate professor emeritus of molecular microbiology at Washington University School of Medicine, died Jan. 18 at his home in Sharon, Mass., from complications following a fall. He was 91.

Seven WashU faculty members are among the 471 new fellows selected by the American Association for the Advancement of Science.

The National Institutes of Health (NIH) is supporting a WashU Medicine effort to track neuroinflammation in the brains of patients with Parkinson’s disease.

Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.

A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.

Jessica Backman-Levy (left), at the Brown School, and Beryne Odeny, MD, PhD, at the School of Medicine, have been selected to participate in a yearlong program aimed at advancing women into senior leadership positions in global health.

The Jansky/Bander Family Fund, a generous commitment of $1.1 million over five years, has been established to advance critical initiatives within the Section of Movement Disorders in the Department of Neurology at WashU Medicine.

Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.

William D. Owens, MD, a highly regarded professor emeritus of anesthesiology and former head of the Department of Anesthesiology at Washington University School of Medicine, died of cancer Jan. 3.

According to a new study by WashU Medicine researchers, male and female rats with a chronic pain condition release different amounts of dopamine when given fentanyl because of sex hormones. The findings might help explain why men have higher rates of opioid use and overdose deaths.